MedPath

University of Iowa

University of Iowa logo
🇺🇸United States
Ownership
Private
Established
1847-02-25
Employees
251
Market Cap
-
Website
http://www.uiowa.edu

Effectiveness of Hearing-aid Based Wind-noise Algorithm

Completed
Conditions
Hearing Impairment
First Posted Date
2008-08-20
Last Posted Date
2011-09-26
Lead Sponsor
University of Iowa
Target Recruit Count
60
Registration Number
NCT00738244
Locations
🇺🇸

Wendell Johnson Center, University of Iowa, Iowa City, Iowa, United States

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

Phase 2
Completed
Conditions
Mouth Neoplasms
Oropharyngeal Neoplasms
Laryngeal Neoplasms
Head and Neck Neoplasms
Interventions
Drug: 18F-Fluorothymidine PET scan
First Posted Date
2008-07-24
Last Posted Date
2019-08-06
Lead Sponsor
University of Iowa
Target Recruit Count
33
Registration Number
NCT00721799
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Zinc to Treat Tinnitus in the Elderly

Phase 2
Completed
Conditions
Tinnitus
Interventions
Drug: Placebo oral capsule
First Posted Date
2008-05-23
Last Posted Date
2017-12-13
Lead Sponsor
University of Iowa
Target Recruit Count
116
Registration Number
NCT00683644
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting

Not Applicable
Completed
Conditions
Stroke
Interventions
Drug: Placebo
Other: Advanced notification
Other: No advanced notification
First Posted Date
2008-01-03
Last Posted Date
2013-01-16
Lead Sponsor
University of Iowa
Target Recruit Count
100
Registration Number
NCT00585351
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

Phase 2
Terminated
Conditions
Ovarian Cancer
Interventions
First Posted Date
2008-01-02
Last Posted Date
2018-01-05
Lead Sponsor
University of Iowa
Target Recruit Count
11
Registration Number
NCT00585052
Locations
🇺🇸

Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

Celecoxib as a Post-tonsillectomy Pain Medication

Phase 2
Completed
Conditions
Tonsillitis
Interventions
Drug: Placebo
First Posted Date
2007-12-31
Last Posted Date
2017-03-29
Lead Sponsor
University of Iowa
Target Recruit Count
18
Registration Number
NCT00583453
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Ultrasound Targeting for the Lumpectomy Cavity

Completed
Conditions
Breast Neoplasms
First Posted Date
2007-12-31
Last Posted Date
2014-01-16
Lead Sponsor
University of Iowa
Target Recruit Count
20
Registration Number
NCT00583843
Locations
🇺🇸

The University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML

Phase 1
Terminated
Conditions
Acute Myeloid Leukemia
Interventions
First Posted Date
2007-12-31
Last Posted Date
2018-01-05
Lead Sponsor
University of Iowa
Target Recruit Count
23
Registration Number
NCT00583102
Locations
🇺🇸

Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

Sulodexide Treatment in Patients With Dense Deposit Disease

Phase 1
Withdrawn
Conditions
Dense Deposit Disease
Interventions
First Posted Date
2007-12-31
Last Posted Date
2015-06-11
Lead Sponsor
University of Iowa
Registration Number
NCT00583427
Locations
🇺🇸

Richard Smith, MD, Iowa City, Iowa, United States

Trental & Vitamin E for Radiation-Induced Fibrosis

Phase 2
Completed
Conditions
Fibrosis
Interventions
First Posted Date
2007-12-31
Last Posted Date
2013-01-29
Lead Sponsor
University of Iowa
Target Recruit Count
54
Registration Number
NCT00583700
Locations
🇺🇸

The University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath